Breaking Therapeutic Inertia in Type 2 Diabetes: Active Detection of In-Patient Cases Allows Improvement of Metabolic Control at Midterm

Table 1

Data of 94 out of 189 patients (group (B)) whose therapeutic changes were performed and were reassessed 3–6 months after discharge.

	Women %	Age (years)	DM evolution (years)	HbA1c PRE (%)	HbA1c POST (%)
94	37 (39.4)	68.94 ± 9.89	12.44 ± 11.88	8.66 ± 1.27	7.50 ± 1.25^*

.
: number of patients.
DM: diabetes mellitus.
HbA_1c PRE: preintervention.
HbA_1c POST: postintervention.